ask="8.99"
ask_size="200"
average_daily_volume="148097"
bid="7.75"
bid_size="1000"
book_value="3.42"
change="-0.03"
change_from_200_day_moving_average="-0.11"
change_from_50_day_moving_average="0.26"
change_from_52_week_high="-4.61"
change_From_52_week_low="2.30"
change_in_percent="-0.38%"
close="7.89"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.07"
ebitda="-1.40M"
eps_estimate_current_year="-2.72"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-3.36"
ex_dividend_date="N/A"
float_shares="4868000"
high="8.20"
high_52_weeks="12.50"
last_trade_date="3/9/2017"
last_trade_price="7.89"
last_trade_size="726"
last_trade_time="4:00pm"
low="7.80"
low_52_weeks="5.59"
market_capitalization="95.97M"
moving_average_200_day="8.00"
moving_average_50_day="7.63"
name="Recro Pharma
Inc."
notes="N/A"
one_year_target_price="20.00"
open="8.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-1.43%"
percent_change_from_50_day_moving_average="+3.47%"
percent_change_from_52_week_high="-36.88%"
percent_change_from_52_week_low="+41.14%"
previous_close="7.92"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.31"
price_per_sales="1.40"
revenue="68.73M"
shares_outstanding="12163000"
short_ratio="4.88"
stock_exchange="NCM"
symbol="REPH"
volume="377924"
weeks_range_52="5.59 - 12.50"
